Members |
targetComponentId |
Romberg's sign |
Romberg sign (finding) |
Rondo spacer device |
Spacer |
Roofer &/or slater |
Slate and tile roofer |
Roofer &/or slater |
Roofer |
Roofer &/or slater |
Tile setter |
Roofer &/or slater |
Roofer |
Roofer &/or slater |
Tile setter |
Roofer &/or slater |
Slate and tile roofer |
Root canal therapy, retreatment of bicuspid, by report |
Revision of root canal treatment of premolar tooth |
Root canal therapy, retreatment of bicuspid, by report |
History of revision of treatment of root canal of premolar tooth (situation) |
Root canal therapy, retreatment of molar, by report |
Revision of root canal treatment of molar tooth |
Root canal therapy, retreatment of molar, by report |
History of revision of treatment of root canal of molar tooth (situation) |
Root canal therapy, retreatment, anterior, by report |
Revision of treatment of root canal of anterior tooth (procedure) |
Root canal therapy, retreatment, anterior, by report |
History of revision of root canal treatment of anterior tooth |
Ropivacaine hydrochloride 10mg/mL injection solution 10mL ampule |
Ropivacaine hydrochloride 10 mg/mL solution for injection |
Ropivacaine hydrochloride 2mg/mL injection solution 10mL ampule |
Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Ropivacaine hydrochloride 7.5mg/mL injection solution 10mL ampule |
Ropivacaine hydrochloride 7.5 mg/mL solution for injection |
Rosa L. pollen allergen |
Rosa L. pollen |
Rosa species diagnostic allergen extract |
Rosa species hip diagnostic allergen extract (product) |
Rosa spp. specific immunoglobulin E |
Immunoglobulin E antibody to Rosa species hip (substance) |
Rosa spp. specific immunoglobulin E antibody measurement |
Measurement of Rosa species hip specific immunoglobulin E antibody (procedure) |
Rose bengal stain |
Rose bengal (substance) |
Rose bengal stain method |
Rose bengal stain technique |
Roseola |
Exanthema subitum (disorder) |
Roseola |
Roseolar erythema (disorder) |
Roseola |
Macular syphilide |
Roseolovirus |
Human herpesvirus 6 |
Roseolovirus |
Genus Roseolovirus (organism) |
Roseomonas species |
Roseomonas |
Rotation flap |
Local flap reconstruction by rotation - action |
Rotation flap |
Flap (substance) |
Rotation of self |
Subjective vertigo (finding) |
Rotation of self |
Objective vertigo |
Rotation of self |
Lightheadedness (finding) |
Rotation of self |
Dizziness and giddiness |
Rotation of self |
Vertigo (finding) |
Rotation of surroundings |
Subjective vertigo (finding) |
Rotation of surroundings |
Lightheadedness (finding) |
Rotation of surroundings |
Dizziness and giddiness |
Rotation of surroundings |
Objective vertigo |
Rotation of surroundings |
Vertigo (finding) |
Rotator cuff decompression: [open acromioplasty] or [Kessel] or [Watson] |
Open acromioplasty for decompression of rotator cuff |
Rotator cuff shoulder syndrome and allied disorders |
Disorder of rotator cuff (disorder) |
Rotator cuff syndrome |
Rupture of rotator cuff of shoulder |
Rotator cuff syndrome |
Disorder of rotator cuff (disorder) |
Rotator cuff syndrome NOS |
Disorder of rotator cuff (disorder) |
Rotator cuff syndrome, unspecified |
Disorder of rotator cuff (disorder) |
Rotaviral gastroenteritis |
Rotavirus food poisoning (disorder) |
Rotavirus food poisoning |
Rotavirus food poisoning (disorder) |
Rotavirus gastroenteritis |
Rotavirus food poisoning (disorder) |
Rotavirus live vaccine powder for 1mL oral suspension + diluent |
Vaccine product containing only live attenuated Rotavirus antigen (medicinal product) |
Rotavirus live vaccine powder for conventional release oral suspension 1mL |
Vaccine product containing only live attenuated Rotavirus antigen (medicinal product) |
Rotavirus vaccine |
Rotavirus antigen-containing vaccine product |
Rotavirus vaccine |
Rotavirus antigen-containing vaccine product |
Rothia species |
Rothia |
Rothmund-Thomson syndrome |
Erythrokeratodermia variabilis |
Rothmund-Thomson syndrome |
Rothmund-Thomson syndrome |
Rotigotine 2mg/24hours transdermal patch |
Rotigotine 83.333 microgram/hour prolonged-release transdermal patch |
Rotigotine 4mg/24hours transdermal patch |
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch |
Rotigotine 6mg/24hours transdermal patch |
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Rough marshelder pollen allergen |
Rough marshelder pollen |
Roundworm |
Ascariasis |
Roundworm |
Nematode |
Roundworm (& ascariasis) |
Nematode |
Roundworm (& ascariasis) |
Ascariasis |
Route |
Route of administration (attribute) |
Route of administration |
Route of administration (attribute) |
Route of administration |
Route of administration value (qualifier value) |
Route of administration of drug |
Route of administration (attribute) |
Roux en Y hepaticojejunostomy & stenting (& [Kasai] or [Rodney-Smith]) |
Anastomosis of hepatic duct to transposed jejunum and insertion of tubal prosthesis |
Roux-en-y procedure biliary atresia (& Sawaguchi) |
Roux-en-Y procedure for biliary atresia |
Royer's syndrome |
Prader-Willi syndrome |
Rubber &/or plastic workers |
Plastic worker |
Rubber &/or plastic workers |
Rubber worker |
Rubber &/or plastic workers |
Rubber worker |
Rubber &/or plastic workers |
Rubber AND/OR plastics product maker |
Rubella and mumps vaccine |
Vaccine product containing Mumps orthorubulavirus antigen (medicinal product) |
Rubella and mumps vaccine |
Vaccine product containing Rubella virus antigen (medicinal product) |
Rubella antibody present - immune |
Rubella antibody detected (finding) |
Rubella antibody present - immune |
Immunity to rubella determined by serology |
Rubella contact |
Exposure to Rubella virus (event) |
Rubella contact |
Exposure to Rubella virus (event) |
Rubella contact in pregnancy |
Exposure to rubella in pregnancy (event) |
Rubella damage in preg. |
Foetal damage from maternal rubella |
Rubella damage in preg. |
Congenital rubella syndrome |
Rubella damage in pregnancy |
Foetal damage from maternal rubella |
Rubella damage in pregnancy |
Congenital rubella syndrome |
Rubella enzyme-linked immunosorbent assay test result, greater than 10iu/ml rubella specific immunoglobulin G detected |
Rubella immune |
Rubella enzyme-linked immunosorbent assay test result, greater than 10iu/ml rubella specific immunoglobulin G detected |
Rubella non-immune |
Rubella enzyme-linked immunosorbent assay test result, greater than 15iu/ml rubella specific immunoglobulin G detected |
Rubella non-immune |
Rubella enzyme-linked immunosorbent assay test result, greater than 15iu/ml rubella specific immunoglobulin G detected |
Rubella immune |
Rubella enzyme-linked immunosorbent assay test result, less than 10iu/ml rubella specific immunoglobulin G detected |
Rubella non-immune |
Rubella enzyme-linked immunosorbent assay test result, less than 10iu/ml rubella specific immunoglobulin G detected |
Rubella immune |
Rubella enzyme-linked immunosorbent assay test result; less than 15iu/ml rubella specific immunoglobulin G detected |
Rubella immune |
Rubella enzyme-linked immunosorbent assay test result; less than 15iu/ml rubella specific immunoglobulin G detected |
Rubella non-immune |
Rubella immunoglobulin 25,000iu powder for injection solution vial |
Product containing only human immunoglobulin (medicinal product) |
Rubella live vaccine powder and solvent for injection solution vial |
Vaccine product containing Rubella virus antigen (medicinal product) |
Rubella live virus vaccine |
Vaccine product containing Rubella virus antigen (medicinal product) |
Rubella vaccine |
Vaccine product containing Rubella virus antigen (medicinal product) |
Rubella vaccine |
Vaccine product containing Rubella virus antigen (medicinal product) |
Rubella with complication |
Disease caused by Rubivirus (disorder) |